TARGET Acute Lymphoblastic Leukemia gene expression

{"cohort":"TARGET Acute Lymphoblastic Leukemia","url":"https://ocg.cancer.gov/programs/target/data-matrix","dataSubType":"phenotype","label":"Phenotypes","tags":["cancer"],"name":"TARGET_ALL/TARGET_public_clinicalMatrix","clinicalfeature":"TARGET_ALL/TARGET_public_clinicalFeature","type":"clinicalMatrix","wrangler":"Chris Szeto","version":"2011-11-11"}

{"longTitle":"TARGET high-risk neuroblastoma gene-level copy number profile","cohort":"TARGET neuroblastoma","url":"http://target.nci.nih.gov/dataMatrix/TARGET_DataMatrix.html","probeMap":"probeMap/hugo_gencode_good_hg19_V24lift37_probemap","dataSubType":"copy number","label":"Copy number (gene-level)","tags":["cancer","Childhood","pediatrics","sympathetic nervous system","neural crest","neuroendocrine"],"anatomical_origin":["Adrenal gland"],"name":"TARGET_neuroblastoma/cnvGene","dataproducer":"NCI TARGET project: Therapeutically Applicable Research To Generate Effective Treatments","sample_type":["tumor"],"type":"genomicMatrix","version":"2014-04-15","unit":"log(tumor/normal)","shortTitle":"Neuroblastoma gene-level CNV (TARGET)","primary_disease":"pediatric high-risk neuroblastoma","description":"TARGET neuroblastoma gene-level copy number variation dataset. <br><br>Neuroblastoma is an embryonal malignancy of early childhood with a poor prognosis for individuals diagnosed at over 18 months of age with disseminated disease, accounting for 12% of all childhood cancer-related deaths.<br><br>"}

TARGET high-risk neuroblastoma gene-level copy number profile

{"longTitle":"TARGET high-risk neuroblastoma copy number profile","cohort":"TARGET neuroblastoma","url":"http://target.nci.nih.gov/dataMatrix/TARGET_DataMatrix.html","probeMap":"TARGET_neuroblastoma/cnv.matrix.probeMap","dataSubType":"copy number","label":"Copy number","tags":["cancer","Childhood","pediatrics","sympathetic nervous system","neural crest","neuroendocrine"],"anatomical_origin":["Adrenal gland"],"name":"TARGET_neuroblastoma/cnv.matrix","dataproducer":"NCI TARGET project: Therapeutically Applicable Research To Generate Effective Treatments","sample_type":["tumor"],"type":"genomicMatrix","version":"2014-04-15","primary_disease":"pediatric high-risk neuroblastoma","description":"TARGET neuroblastoma copy number variation dataset by microarray. <br><br>Neuroblastoma is an embryonal malignancy of early childhood with a poor prognosis for individuals diagnosed at over 18 months of age with disseminated disease, accounting for 12% of all childhood cancer-related deaths.<br><br>"}